title: Secondary progression and innate immunity in NMO: A possible link to alemtuzumab therapy?
authors.affiliation: Departments of Multiple Sclerosis Therapeutics (K.F.) and Neurology (K.F., I.N.), Tohoku University Graduate School of Medicine, Sendai, Japan.
authors.forename: Kazuo
authors.initials: K
authors.lastname: Fujihara
authors.affiliation: Departments of Multiple Sclerosis Therapeutics (K.F.) and Neurology (K.F., I.N.), Tohoku University Graduate School of Medicine, Sendai, Japan.
authors.forename: Ichiro
authors.initials: I
authors.lastname: Nakashima